Cargando…
Effect of Sertraline as an Add-on Therapy in T2DM Patients with Comorbid Depression: An Open Label Randomized Controlled Trial
OBJECTIVES: To study the effect of sertraline on depression in type 2 diabetes mellitus (T2DM) patients with comorbid depression. MATERIALS AND METHODS: An open label randomized control study. Patients with T2DM and moderate to severe depression were randomized to sertraline or control therapy for s...
Autores principales: | Kumar, Padala R., Chatterjee, Anindita, P. Behera, Jayanti, Patnaik, Sudhiranjan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683678/ https://www.ncbi.nlm.nih.gov/pubmed/31641639 http://dx.doi.org/10.4103/ijem.IJEM_67_19 |
Ejemplares similares
-
Randomized trial of vilazodone versus sertraline in depression: Concerns and comments
por: Praharaj, Samir Kumar
Publicado: (2021) -
Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
por: Simon, Maria S., et al.
Publicado: (2021) -
Open-label, add-on trial of cetirizine for neuromyelitis optica
por: Katz Sand, Ilana, et al.
Publicado: (2018) -
Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010) -
Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study
por: Rhein, Joshua, et al.
Publicado: (2016)